Mechanisms of Graft Rejection: Lessons Learned from Pathology - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Mechanisms of Graft Rejection: Lessons Learned from Pathology

Description:

Mechanisms of Graft Rejection: Lessons Learned from Pathology ... bronchi. crypts. Antibody-mediated rejection. The target. Endothelium of arteries, capillaries ... – PowerPoint PPT presentation

Number of Views:287
Avg rating:3.0/5.0
Slides: 37
Provided by: path192
Category:

less

Transcript and Presenter's Notes

Title: Mechanisms of Graft Rejection: Lessons Learned from Pathology


1
Mechanisms of Graft Rejection Lessons Learned
from Pathology
  • Lorraine C. Racusen, M.D.
  • The Johns Hopkins University
  • Baltimore

2
Rejection as an Inflammatory/Immune Process
3
Cells Involved in/Diagnostic ofAcute Rejection
4
Acute Rejection - cell-mediated
  • The effector cells
  • Morphology - mononuclear
  • lymphocytic
  • Immunophenotyping
  • CD8 gt CD4 - ?/?, ?/?
  • CD45RO gt RA
  • perforin/granzyme/CD57 - cytotoxic cells
  • Other cells - eosinophils
  • plasma cells

5
Acute Rejection - antibody mediated
  • Effectors
  • Complement
  • Neutrophils
  • Platelets

6
Tissue Targets of the Acute Rejection Reaction
7
Acute Rejection - cell-mediated
  • The targets
  • Vessels - arteries
  • capillaries
  • Parenchymal - tubules
  • ducts
  • myocardium
  • hepatocytes
  • acini
  • bronchi
  • crypts

8
Antibody-mediated rejection
  • The target
  • Endothelium of arteries, capillaries
  • HLA antigens - class I, class II,
  • Endothelial antigens

9
Antibody - mediated rejection
  • Morphologic clues may lead to diagnosis
  • Marginating cells - neutrophils, mononuclear
  • Early/severe arteritis/fibrinoid necrosis
  • Thromboses
  • Hemorrhage/infarction
  • Complement deposition

10
Molecular mechanisms of Acute Rejection
11
Acute Rejection - cell mediated
  • The molecules
  • Antigens/neo-antigens - Class II, Class I
  • Adhesion molecules - V-CAM, I-CAM
  • Cytokines - IL - 2
  • Demonstrable by immunohistology, PCR

12
Antibody-mediated rejection
  • The molecules
  • Antibodies - IgG (esp. IgG3), IgM
  • Complement - new focus on C3d, C4d

13
Mechanisms of Tissue Injury
14
Acute Rejection
  • Mechanisms of Tissue Injury
  • Organ - Cytotoxicity
  • Ischemia
  • Cells - Sublethal Injury
  • Necrosis
  • Apoptosis
  • Severity - Reversible
  • Irreversible

15
Concept of Tissue Priming for Rejection
16
Acute Rejection - cell-mediated
  • Targeting mechanisms
  • ? or new expression of HLA antigens - DR
  • ? expression of adhesion molecules
  • I-CAM-1
  • VCAM-1
  • ? IFN-?, 1L-2 receptors

17
Corollary Not all leukocytic infiltrates in
allografts are a response to allo-antigen
18
Inflammation in the Allograft
  • Pre-existing
  • Ischemia
  • Infection
  • bacterial
  • viral
  • Drug reaction
  • Neoplastic - PTLD
  • Non-specific
  • Acceptance reaction

19
Acceptance Reactions
  • Recognizable in experimental models
  • T-lymphocytes and monocyte/macrophages
  • no vasculitis, may be tubulitis
  • less T cell activation, apoptosis than rejection
  • ? interferon, ? IL-10 compared to rejection
  • Cytotoxic cells present
  • NOT BEING RECOGNIZED CLINICALLY

20
Criteria for diagnosis of rejection
21
Morphologic Bases of Diagnosis of Rejection
22
The concept of subclinical rejection
23
Morphologic predictors - of refractory
rejection of later functional loss
24
Cells Involved in Chronic Rejection
25
Acute Rejection
  • Pathologic Findings Predicting Refractory
    Rejection
  • Intimal arteritis
  • Severe acute glomerulitis
  • Necrotizing arteritis
  • Interstitial hemorrhage
  • Numerous eosinophils, plasma cells,
  • monocyte/macrophages
  • CD8 - rich infiltrate

26
Cells involved in Chronic Rejection
27
Chronic Rejection
  • The Cells
  • Monocyte/macrophage - IL2R
  • Fibroblast/myofibroblast
  • T cells - CD4

28
Tissue Targets of Chronic Rejection
29
Chronic Rejection
  • The targets
  • Parenchymal elements
  • most closely correlated with outcome
  • the final common pathway
  • Arteries
  • lesions often not sampled on Bx
  • Capillary lesions
  • better sampled

30
Molecular Mechanisms of Chronic Rejection
31
Chronic Rejection
  • The Molecules
  • Fibrogenic Factors
  • TGF, FGF, PDGF
  • Macrophage-associated
  • RANTES, MCP-1, IL-6
  • Cytokines
  • IFN, TNF

32
Molecular Pathology of Acute and Chronic
Rejection
33
Not all chronic change in the allograft
represents a chronic alloimmune response
34
Causes of fibrosis in the allograft
  • Chronic rejection
  • Infection
  • Drug toxicity
  • Atherosclerosis/hypertensive
  • vascular disease
  • Obstruction
  • Recurrent disease
  • Donor-related

35
Early Prediction
  • Rejection too patchy a process for biopsy to be
    useful

36
Critical Pathologic Data
  • Nature of infiltrates
  • Localization of infiltrates
  • Predictive features
  • Differential diagnoses
  • Molecular milieu
Write a Comment
User Comments (0)
About PowerShow.com